SIRT5 and breast carcinoma: DK1-–04e is a selective, cell-permeable, and potent small-molecule SIRT5 inhibitor that effectively inhibits the growth of breast cancer cells in vitro and significantly suppresses mammary tumor development in vivo (Figure 6 and Table 2).